drugset / Trial / NCT00164125

An Open Label Study of Chronic Polyethyleneglycol3350 Use in Constipated Patients

NCT00164125

Phase 4 Completed 300 enrolled Braintree Laboratories
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To evaluate the safety of extended use of polyethyleneglycol3350 laxative in constipated patients.

Timeline

Start
2003-07
Primary completion
2004-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject polyethylene glycol Other / unclassified

Indications